Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Curr Opin Endocrinol Diabetes Obes. 2017 Aug;24(4):285–291. doi: 10.1097/MED.0000000000000348

Figure 1.

Figure 1

Comparison of predictive values between ECL and radioassays on 2,944 subjects for their very first initial screening samples in TrialNet Pathway to Prevention Study.

Panel A: Comparison of positive predictive values between RBA-IAA (mIAA) and ECL-IAA (p<0.0001), and between RBA-GADA and ECL-GADA (p<0.0001).

Panel B: Comparison of negative predictive values between RBA-IAA (mIAA) and ECL-IAA (p<0.05), and between RBA-GADA and ECL-GADA (p=0.007).

[11] Diabetes Technol Ther. 2015;17:119–27.